Table 4.
Breast Morphological Stage | LH (IU/L) | FSH (IU/L) | E2 (pg/mL) | E1 (ng/dL) | TT (ng/dL) | AD (ng/dL) |
---|---|---|---|---|---|---|
A | 0.05 (0.04–0.07) | 1.14 (0.98–1.77) | 1.22 (1.22–3.08) | 0.46 (0.39–0.59) | 6.59 (3.09–8.53) | 22.39 (13.47–30.31) |
B | 0.10 (0.06–1.42) | 1.64 (0.94–2.77) | 2.21 (1.22–5.01) | 0.78 (0.52–3.01) | 8.76 (5.53–11.21) | 23.67 (18.12–34.04) |
C | 0.27 (0.08–1.52) | 2.54 (1.87–4.03) | 5.96 (1.22–11.38) | 1.04 (0.63–1.72) | 9.19 (5.96–11.58) | 35.72 (26.73–50.44) |
D | 1.81 (1.22–3.37) | 4.31 (3.48–5.36) | 15.85 (8.78–33.65) | 2.23 (1.70–2.86) | 16.60 (13.75–22.99) | 68.93 (51.56–89.53) |
E | 1.95 (0.77–3.04) | 3.96 (2.86–5.31) | 20.46 (6.28–29.58) | 2.12 (1.54–2.95) | 11.79 (9.27–20.07) | 61.58 (46.84–81.37) |
Data is presented as median (IQR). All hormones increased linearly with breast maturation, p<0.001. To convert E2 to SI units (pmol/L), multiply by 3.67; for E1 (pmol/L), multiply by 3.69; for AD (nmol/L), multiply by 0.0349; for TT (nmol/L), multiply by 0.0347.